Gene · 476
Papers2,080
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,080
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SNX27-driven membrane localisation of OTULIN antagonises linear ubiquitination and NF-κB signalling activation. | Cell Biosci | 2021 | 34315543 | PubTator, text mining | PubMed |
| A Novel Microphysiological Colon Platform to Decipher Mechanisms Driving Human Intestinal Permeability. | Cell Mol Gastroenterol Hepatol | 2021 | 34284165 | PubTator, text mining | PubMed |
| Cardiac Glycoside Ouabain Exerts Anticancer Activity via Downregulation of STAT3. | Front Oncol | 2021 | 34277430 | PubTator, text mining | PubMed |
| Approaches to Gene Mutation Analysis Using Formalin-Fixed Paraffin-Embedded Adrenal Tumor Tissue From Patients With Primary Aldosteronism. | Front Endocrinol (Lausanne) | 2021 | 34267727 | PubTator, text mining | PubMed |
| The expression of the alpha1 subunit of Na+/K+-ATPase is related to tumor development and clinical outcomes in gastric cancer. | Gastric Cancer | 2021 | 34251542 | PubTator, text mining | PubMed |
| Global mapping of Salmonella enterica-host protein-protein interactions during infection. | Cell Host Microbe | 2021 | 34237247 | PubTator, text mining | PubMed |
| Diseases caused by mutations in the Na+/K+ pump α1 gene ATP1A1. | Am J Physiol Cell Physiol | 2021 | 34232746 | PubTator, text mining | PubMed |
| FXYD6 Regulates Chemosensitivity by Mediating the Expression of Na+/K+-ATPase α1 and Affecting Cell Autophagy and Apoptosis in Colorectal Cancer. | Biomed Res Int | 2021 | 34212047 | PubTator, text mining | PubMed |
| Progress in Anti-Mammarenavirus Drug Development. | Viruses | 2021 | 34206216 | PubTator, text mining | PubMed |
| In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer. | Cell Rep Med | 2021 | 34195683 | PubTator, text mining | PubMed |
| Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation. | Environ Int | 2021 | 34186270 | PubTator, text mining | PubMed |
| Controllable Drug Delivery by Na+/K+ ATPase α1 Targeting Peptide Conjugated DSPE-PEG Nanocarriers for Breast Cancer. | Technol Cancer Res Treat | 2021 | 34180301 | PubTator, text mining | PubMed |
| Coupling of Cell Surface Biotinylation and SILAC-Based Quantitative Proteomics Identified Myoferlin as a Potential Therapeutic Target for Nasopharyngeal Carcinoma Metastasis. | Front Cell Dev Biol | 2021 | 34178975 | PubTator, text mining | PubMed |
| Early role for a Na+,K+-ATPase (ATP1A3) in brain development. | Proc Natl Acad Sci U S A | 2021 | 34161264 | PubTator, text mining | PubMed |
| MI_DenseNetCAM: A Novel Pan-Cancer Classification and Prediction Method Based on Mutual Information and Deep Learning Model. | Front Genet | 2021 | 34149811 | PubTator, text mining | PubMed |
| Tubulopathy meets Sherlock Holmes: biochemical fingerprinting of disorders of altered kidney tubular salt handling. | Pediatr Nephrol | 2021 | 34143300 | PubTator, text mining | PubMed |
| Optimization of a modeling platform to predict oncogenes from genome-scale metabolic networks of non-small-cell lung cancers. | FEBS Open Bio | 2021 | 34137202 | PubTator, text mining | PubMed |
| PRRT2 modulates presynaptic Ca2+ influx by interacting with P/Q-type channels. | Cell Rep | 2021 | 34133925 | PubTator, text mining | PubMed |
| Recent advances in potential drug therapies combating COVID-19 and related coronaviruses-A perspective. | Food Chem Toxicol | 2021 | 34118347 | PubTator, text mining | PubMed |
| Quantitative proteomics identifies the core proteome of exosomes with syntenin-1 as the highest abundant protein and a putative universal biomarker. | Nat Cell Biol | 2021 | 34108659 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/476/papers?page=34